Semustine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Semustine, covering 2013-06-24 to 2017-05-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) [Phase 3]